News
Anesthesia: resuscitating patients within minutes, regardless of the NMBA used
The neuromuscular blockade reversal agents, capable of reversing the effect of neuromuscular blocking agents (NMBAs) at the end of anesthesia and therefore restoring muscle function upon resuscitation, represent a medical and economic breakthrough. A team led by Institut Pasteur scientist Pierre Bruhns has worked on the development a new generation of neuromuscular blockade reversal agents.